<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Avalere Health Advisory</provider_name><provider_url>https://advisory.avalerehealth.com</provider_url><title>White Paper: The Medicaid Drug Rebate Program and Considerations for Generic Markets | Avalere Health Advisory</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="xOpVSQsocI"&gt;&lt;a href="https://advisory.avalerehealth.com/insights/white-paper-the-medicaid-drug-rebate-program-and-considerations-for-generic-markets"&gt;White Paper: The Medicaid Drug Rebate Program and Considerations for Generic Markets&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://advisory.avalerehealth.com/insights/white-paper-the-medicaid-drug-rebate-program-and-considerations-for-generic-markets/embed#?secret=xOpVSQsocI" width="600" height="338" title="&#x201C;White Paper: The Medicaid Drug Rebate Program and Considerations for Generic Markets&#x201D; &#x2014; Avalere Health Advisory" data-secret="xOpVSQsocI" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
&lt;/script&gt;
</html><thumbnail_url>https://advisory.avalerehealth.com/wp-content/uploads/2023/06/17348-1-Margaret_Scott_600x400.jpg</thumbnail_url><thumbnail_width>600</thumbnail_width><thumbnail_height>400</thumbnail_height><description>Generic drugs play a key role in the US healthcare system. In Medicaid, coverage of outpatient prescription drugs is governed by the Medicaid Drug Rebate Program (MDRP), which requires manufacturers to pay rebates in return for guaranteed coverage. These rebates include a base rebate and an inflation rebate that applies when a drug&#x2019;s average manufacturer&hellip;</description></oembed>
